Table 1.
Condition | Prevalence in psoriasis n (%) | Hospital controls OR (95% CI) |
RKI sample OR (95% CI) |
---|---|---|---|
Diabetes mellitus type I | 11 (1.9) | 3.99 (1.30–12.2)* | 6.34 (2.80–14.3)*** |
Diabetes mellitus type II | 68 (11.7) | 2.48 (1.70–3.61)** | 2.07 (1.50–2.85)*** |
Arterial hypertension | 127 (21.9) | 3.27 (2.41–4.43)*** | 1.39 (1.09–1.77)* |
Hyperlipoproteinemia | 30 (5.2) | 2.09 (1.23–3.54)** | 0.83 (0.54–1.28)f |
Coronary heart disease | 32 (5.5) | 1.77 (1.07–2.93)* | 0.93(0.60–1.43)f |
Metabolic syndrome | 25 (4.3) | 5.92 (2.78–12.8)*** | 2.20 (1.41–3.43)** |
Alcohol consumption none vs. moderate | 246 (42.3) | 2.78 (2.14–3.62)*** | 2.03 (1.62–2.55)*** |
None vs. regularly | 75 (12.9) | 3.33 (2.20–5.05)*** | 2.00 (1.45–2.77)*** |
None vs. heavya | 24 (4.1) | 3.61 (1.85–7.07)*** | 8.50 (5.28–16.8)*** |
Cigarette smoking | 264 (45.4) | 2.96 (2.27–3.84)*** | 2.49 (2.00–3.10)*** |
The prevalence of diseases in plaque-type psoriasis patients (n = 581) was compared with hospital-based controls (n = 1,044) and a population-based survey (RKI sample; n = 4,705). Common odds ratios adjusted for age and sex are presented with their 95% confidence intervals (95% CI), f not significant
aDue to low numbers, only adjusted for sex
*P < 0.05; ** P < 0.01; ***P < 0.0001 by Mantel–Haenszel test